|
|
||||||||
The Journal of Immunology, Vol 149, Issue 5 1599-1604, Copyright © 1992 by American Association of Immunologists
ARTICLES |
F Zhou, BT Rouse and L Huang
Department of Biochemistry, University of Tennessee, Knoxville 37996.
Intravenous administration of APC such as splenocytes loaded with a soluble protein Ag has been shown to prime for an Ag-specific CTL response. It is thought that the APC directly presents loaded Ag in a MHC-restricted manner. However, it is demonstrated in this study that allogeneic splenocytes, MHC-free RBC, and even synthetic lipid vesicles (liposomes) after loading with OVA can elicit an OVA-specific and MHC- restricted CTL response. Biodistribution studies of these Ag-associated vehicles showed that the liver, spleen, and lung were the major organs responsible to scavenge these carriers, suggesting that the monocyte- macrophage system was involved in the Ag presentation for CTL. Depletion of macrophages by a specific macrophage killer, Cl2MDP, containing liposomes, abolished the CTL induction by immunization with OVA Ag carried by these vehicles except the induction by syngeneic splenocytes. Thus, the syngeneic splenocytes present Ag directly to the T cells, but other membranous vehicles carry the Ag to the host APC including macrophages, which then present it to the T cells. These results indicate that formulation of an Ag in membranous/colloidal vehicles may be a way to prime for a CTL response.
This article has been cited by other articles:
![]() |
F. Boisgerault, P. Rueda, C. M. Sun, S. Hervas-Stubbs, M. Rojas, and C. Leclerc Cross-Priming of T Cell Responses by Synthetic Microspheres Carrying a CD8+ T Cell Epitope Requires an Adjuvant Signal J. Immunol., March 15, 2005; 174(6): 3432 - 3439. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yao, R. Zhang, L. Guo, M. Li, and C. Chen Th Cell-Independent Immune Responses to Chimeric Hemagglutinin/Simian Human Immunodeficiency Virus-Like Particles Vaccine J. Immunol., August 1, 2004; 173(3): 1951 - 1958. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Deliyannis, D. C. Jackson, N. J. Ede, W. Zeng, I. Hourdakis, E. Sakabetis, and L. E. Brown Induction of Long-Term Memory CD8+ T Cells for Recall of Viral Clearing Responses against Influenza Virus J. Virol., March 27, 2002; 76(9): 4212 - 4221. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ada Vaccines and Vaccination N. Engl. J. Med., October 4, 2001; 345(14): 1042 - 1053. [Full Text] [PDF] |
||||
![]() |
R. Ignatius, K. Mahnke, M. Rivera, K. Hong, F. Isdell, R. M. Steinman, M. Pope, and L. Stamatatos Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo Blood, November 15, 2000; 96(10): 3505 - 3513. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Blanas, G. M. Davey, F. R. Carbone, and W. R. Heath A Bone Marrow-Derived APC in the Gut-Associated Lymphoid Tissue Captures Oral Antigens and Presents Them to Both CD4+ and CD8+ T Cells J. Immunol., March 15, 2000; 164(6): 2890 - 2896. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Maitre, J. M. Brown, M. Demcheva, J. R. Kelley, M. A. Lockett, J. Vournakis, and D. J. Cole Primary T-Cell and Activated Macrophage Response Associated with Tumor Protection Using Peptide/Poly-N-Acetyl Glucosamine Vaccination Clin. Cancer Res., May 1, 1999; 5(5): 1173 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Liebana, R. M. Girvin, M. Welsh, S. D. Neill, and J. M. Pollock Generation of CD8+ T-Cell Responses to Mycobacterium bovis and Mycobacterial Antigen in Experimental Bovine Tuberculosis Infect. Immun., March 1, 1999; 67(3): 1034 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Brewer, L. Tetley, J. Richmond, F. Y. Liew, and J. Alexander Lipid Vesicle Size Determines the Th1 or Th2 Response to Entrapped Antigen J. Immunol., October 15, 1998; 161(8): 4000 - 4007. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. M. Toes, E. I. H. van der Voort, S. P. Schoenberger, J. W. Drijfhout, L. van Bloois, G. Storm, W. M. Kast, R. Offringa, and C. J. M. Melief Enhancement of Tumor Outgrowth Through CTL Tolerization After Peptide Vaccination Is Avoided by Peptide Presentation on Dendritic Cells J. Immunol., May 1, 1998; 160(9): 4449 - 4456. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sedlik, M.-F. Saron, J. Sarraseca, I. Casal, and C. Leclerc Recombinant parvovirus-like particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells PNAS, July 8, 1997; 94(14): 7503 - 7508. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |